epigallocatechin gallate has been researched along with Cardiovascular Diseases in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 17 (51.52) | 24.3611 |
| 2020's | 7 (21.21) | 2.80 |
| Authors | Studies |
|---|---|
| Karim, MR; Li, Y; Peng, J; Wang, B | 1 |
| Alemi, F; Karimian, A; Majidinia, M; Safa, A; Yousefi, B | 1 |
| Sharma, A; Thakur, A; Tuli, HS | 1 |
| Athukorala, M; Evans, LW; Ferguson, BS; Martinez-Guryn, K | 1 |
| Iacobazzi, D; Montagnani, M; Potenza, MA; Sgarra, L | 1 |
| Cao, M; Fang, F; Zhang, S | 1 |
| Benlloch, M; Carrera-Juliá, S; Ceron, JJ; Cuerda Ballester, M; de la Rubia Ortí, JE; Drehmer, E; López-Rodríguez, MM; Moreno, ML; Navarro, MÁ; Platero, JL; Tvarijonaviciute, A | 1 |
| Carter, SE; de Graaf, Y; Draijer, R; Holder, SM; Hopkins, ND; Low, DA; Roberts, KA; Thijssen, DHJ | 1 |
| Eng, QY; Ramamurthy, S; Thanikachalam, PV | 1 |
| Yang, CS; Zhang, J | 1 |
| Yamagata, K | 1 |
| Andriantsitohaina, R; Clere, N; Dayoub, O | 1 |
| Arazi, H; Kheirkhah, J; Samami, N; Taati, B | 1 |
| Keske, MA; Kim, JA; Munir, K; Ng, HL; Premilovac, D; Quon, MJ; Rattigan, S; Yang, P | 1 |
| Tagami, M; Yamagata, K; Yamori, Y | 1 |
| Chakraborti, S; Chakraborti, T; Chowdhury, A; Sarkar, J | 1 |
| Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L | 1 |
| Alfonso, H; Hiramatsu, N; Ishisaka, A; Lee, AH; Takechi, R; Tan, L; Tanaka, A | 1 |
| Goto, S; Isemura, M; Monira, P; Nakamura, Y; Ohishi, T | 1 |
| Babu, PV; Liu, D | 1 |
| Hescheler, J; Jagtap, S; Meganathan, K; Sachinidis, A; Wagh, V; Winkler, J | 1 |
| Jackson, KG; Minihane, AM; Moore, RJ | 1 |
| Aston, CE; Basu, A; Betts, NM; Blevins, S; Du, M; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M | 1 |
| Gradinaru, D; Ilie, M; Margina, D | 1 |
| Matsui, T; Suyama, A; Tanaka, M; Zhao, J | 1 |
| Han, CJ; Li, M; Liu, JT; Mao, JJ; Pang, XM | 1 |
| Auger, C; Ito, T; Kim, JH; Kinoshita, Y; Kurita, I; Miyase, T; Schini-Kerth, VB | 1 |
| Frei, B; Higdon, JV | 1 |
| Cheng, TO | 1 |
| Artacho, R; Cabrera, C; Giménez, R | 1 |
| Wolfram, S | 1 |
| Shenouda, SM; Vita, JA | 1 |
| Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
22 review(s) available for epigallocatechin gallate and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Green Tea (-)-Epigallocatechin-3-Gallate (EGCG) on Cardiac Function - A Review of the Therapeutic Mechanism and Potentials.
Topics: Antioxidants; Calcium; Cardiovascular Diseases; Catechin; Heart Diseases; Humans; Inflammation; Tea | 2022 |
Targeting miRNAs by polyphenols: Novel therapeutic strategy for aging.
Topics: Aging; Cardiovascular Diseases; Catechin; Gene Expression Regulation; Humans; Longevity; MicroRNAs; Neoplasms; Nervous System Diseases; Polyphenols | 2020 |
The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases.
Topics: Acetylation; Animals; Cardiovascular Diseases; Catechin; Curcumin; Epigenesis, Genetic; Histone Deacetylases; Histones; Humans; Microbiota; Phytochemicals; Protein Processing, Post-Translational; Resveratrol | 2020 |
The Intrinsic Virtues of EGCG, an
Topics: Animals; Antioxidants; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Obesity; Signal Transduction | 2020 |
The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseases.
Topics: Apoptosis; Autophagy; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Neoplasms; Nervous System Diseases; Signal Transduction | 2020 |
Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
Topics: Animals; Anti-Inflammatory Agents; Camellia sinensis; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Humans; Metabolic Diseases; Tea | 2018 |
Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities.
Topics: Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Humans; Neoplasms; Randomized Controlled Trials as Topic; Tea | 2019 |
Polyphenols Regulate Endothelial Functions and Reduce the Risk of Cardiovascular Disease.
Topics: Antioxidants; Cardiovascular Diseases; Catechin; Diet; Endothelium, Vascular; Flavonoids; Humans; Polyphenols; Quercetin; Resveratrol | 2019 |
Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction.
Topics: Anthocyanins; Antioxidants; Apoptosis; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Humans; Quercetin; Reactive Oxygen Species | 2013 |
Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.
Topics: Adipose Tissue; Animals; Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Liver; Muscle, Skeletal; Nitric Oxide; Tea | 2015 |
Dietary polyphenols regulate endothelial function and prevent cardiovascular disease.
Topics: Administration, Oral; Animals; Apigenin; Aryldialkylphosphatase; Cardiovascular Diseases; Catechin; Diet; Disease Models, Animal; Endothelial Cells; Endothelin-1; Humans; Lipoproteins, HDL; Nitric Oxide; Nitric Oxide Synthase Type III; Polyphenols; Signal Transduction; U937 Cells | 2015 |
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss | 2016 |
Anti-inflammatory Action of Green Tea.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Inflammation Mediators; Neoplasms; Neurodegenerative Diseases; Obesity; Reactive Oxygen Species; Tea | 2016 |
Green tea catechins and cardiovascular health: an update.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Platelets; Cardiovascular Diseases; Cardiovascular System; Catechin; Cell Proliferation; Endothelial Cells; Humans; Inflammation; Lipids; Models, Chemical; Oxidative Stress; Tea | 2008 |
Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases.
Topics: Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Catechin; Curcumin; Humans; Models, Biological; Molecular Structure; Neoplasms; Oxidative Stress; Quercetin | 2009 |
Green tea (Camellia sinensis) catechins and vascular function.
Topics: Animals; Atherosclerosis; Biological Availability; Blood Vessels; Camellia sinensis; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Catechin; Endothelium, Vascular; Flavonoids; Homeostasis; Humans; Phenols; Phytotherapy; Polyphenols; Signal Transduction; Tea | 2009 |
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions.
Topics: Animals; Antioxidants; Biological Availability; Biomarkers; Cardiovascular Diseases; Catechin; Chronic Disease; Flavonoids; Free Radical Scavengers; Humans; Neoplasms; Oxidative Stress; Phenols; Polymers; Reactive Oxygen Species; Tea | 2003 |
All teas are not created equal: the Chinese green tea and cardiovascular health.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Catechin; Diabetes Mellitus; Endothelium, Vascular; Humans; Metabolic Syndrome; Obesity; Phytotherapy; Plant Extracts; Tea | 2006 |
Beneficial effects of green tea--a review.
Topics: Anticarcinogenic Agents; Antihypertensive Agents; Antimutagenic Agents; Antioxidants; Biological Availability; Camellia sinensis; Cardiovascular Diseases; Catechin; Flavonoids; Health Promotion; Humans; Nutritive Value; Obesity; Phenols; Polyphenols; Tea | 2006 |
Effects of green tea and EGCG on cardiovascular and metabolic health.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Metabolism; Humans; Insulin Resistance; Obesity; Tea | 2007 |
Effects of flavonoid-containing beverages and EGCG on endothelial function.
Topics: Antioxidants; Atherosclerosis; Beverages; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Flavonoids; Humans; Risk Factors | 2007 |
A new function of green tea: prevention of lifestyle-related diseases.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Catechin; Cohort Studies; Cricetinae; Female; Gene Expression Regulation; Humans; Interleukin-6; Japan; Life Style; Lung; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; NF-kappa B; Okadaic Acid; Phytotherapy; Primary Prevention; Prospective Studies; Pulmonary Fibrosis; Rats; Risk; Tea; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2001 |
3 trial(s) available for epigallocatechin gallate and Cardiovascular Diseases
| Article | Year |
|---|---|
Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study.
Topics: 3-Hydroxybutyric Acid; Adult; Analysis of Variance; Anthropometry; Aryldialkylphosphatase; Body Mass Index; C-Reactive Protein; Cardiotonic Agents; Cardiovascular Diseases; Catechin; Dietary Supplements; Female; Heart Disease Risk Factors; Humans; Ketone Bodies; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Serum Albumin; Treatment Outcome; Waist-Height Ratio | 2020 |
The effect of three weeks green tea extract consumption on blood pressure, heart rate responses to a single bout resistance exercise in hypertensive women.
Topics: Adult; Analysis of Variance; Antioxidants; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension; Middle Aged; Plant Extracts; Resistance Training; Risk Factors; Tea; Treatment Outcome | 2014 |
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Camellia sinensis; Cardiovascular Diseases; Catechin; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Plant Extracts; Single-Blind Method; Tea; Vascular Cell Adhesion Molecule-1 | 2011 |
8 other study(ies) available for epigallocatechin gallate and Cardiovascular Diseases
| Article | Year |
|---|---|
Natural Moieties as Anti-Inflammatory Agents-Recent Patents.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Biological Products; Cardiovascular Diseases; Catechin; Coumaric Acids; Humans; Inflammation; Neoplasms; Neurodegenerative Diseases; Patents as Topic; Plants; Polyphenols; Quercetin | 2019 |
Impact of green tea on the deleterious cardiometabolic effects of 7-days unhealthy lifestyle in young healthy males.
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Catechin; Double-Blind Method; Humans; Insulin; Life Style; Male; Middle Aged; Postprandial Period; Tea; Young Adult | 2021 |
Role of Spm-Cer-S1P signalling pathway in MMP-2 mediated U46619-induced proliferation of pulmonary artery smooth muscle cells: protective role of epigallocatechin-3-gallate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Cattle; Cell Culture Techniques; Cell Proliferation; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocytes, Smooth Muscle; Pulmonary Artery; Vasoconstrictor Agents | 2015 |
Elevated plasma and urinary concentrations of green tea catechins associated with improved plasma lipid profile in healthy Japanese women.
Topics: Adipose Tissue; Adult; Aged; Asian People; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Catechin; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Japan; Middle Aged; Plant Extracts; Tea; Triglycerides | 2016 |
Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells.
Topics: Adult; Aged; Anisotropy; Biomarkers; Cardiovascular Diseases; Catechin; Cell Membrane; Cell Polarity; Diabetes Mellitus, Type 2; Diet, Vegetarian; Female; Humans; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Leukocytes, Mononuclear; Male; Membrane Fluidity; Membrane Potentials; Middle Aged; Quercetin; Resistin | 2012 |
Epigallocatechin gallate promotes the vasorelaxation power of the antiatherosclerotic dipeptide Trp-His in contracted rat aorta.
Topics: Animals; Aorta; Cardiovascular Diseases; Catechin; Dipeptides; Drug Synergism; Humans; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 2012 |
Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages.
Topics: Angiotensin II; Anti-Inflammatory Agents; C-Reactive Protein; Cardiovascular Diseases; Catechin; Cell Line, Tumor; Humans; Inflammation; Interleukin-6; Macrophages; Reactive Oxygen Species; RNA, Messenger; Tea; U937 Cells | 2012 |
Hydroxylation of (-)-epigallocatechin-3-O-gallate at 3'', but not 4'', is essential for the PI3-kinase/Akt-dependent phosphorylation of endothelial NO synthase in endothelial cells and relaxation of coronary artery rings.
Topics: Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Coronary Vessels; Endothelial Cells; Humans; Hydroxylation; In Vitro Techniques; Molecular Structure; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Swine; Vasodilation | 2013 |